KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Hologic (HOLX) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Hologic (HOLX) over the last 3 years, with Q4 2025 value amounting to $196.7 million.

Hologic's Short-term Investments rose 320.04% to $196.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $196.7 million, marking a year-over-year increase of 320.04%. This contributed to the annual value of $243.2 million for FY2025, which is 4025.37% up from last year.
As of Q4 2025, Hologic's Short-term Investments stood at $196.7 million, which was up 320.04% from $243.2 million recorded in Q3 2025.
Hologic's Short-term Investments' 5-year high stood at $243.2 million during Q3 2025, with a 5-year trough of $143.9 million in Q2 2025.